rofecoxib has been researched along with Nerve Degeneration in 2 studies
Nerve Degeneration: Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Scali, C | 1 |
| Giovannini, MG | 1 |
| Prosperi, C | 1 |
| Bellucci, A | 1 |
| Pepeu, G | 1 |
| Casamenti, F | 1 |
| Hewett, SJ | 1 |
| Silakova, JM | 1 |
| Hewett, JA | 1 |
2 other studies available for rofecoxib and Nerve Degeneration
| Article | Year |
|---|---|
The selective cyclooxygenase-2 inhibitor rofecoxib suppresses brain inflammation and protects cholinergic neurons from excitotoxic degeneration in vivo.
Topics: Alzheimer Disease; Animals; Astrocytes; Brain; Cell Death; Choline O-Acetyltransferase; Cholinergic | 2003 |
Oral treatment with rofecoxib reduces hippocampal excitotoxic neurodegeneration.
Topics: Animals; Blotting, Western; Brain Edema; Cell Death; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inh | 2006 |